Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Titan Machinery Inc. | 32,145 | reported | 02 Jun 2025 | tx 9+32,145 |
| SAB Biotherapeutics, Inc. | 20,000 | reported | 15 Jul 2024 | tx 30+15,268,720−2,000,000 |
| HF FINANCIAL CORP | 11,319 | reported | 17 Nov 2010 | tx 7+8,466 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 02 Jun 2025 | GRANT_AWARD | Titan Machinery Inc. | 4,322 | 0.00 USD | |
| 15 Jul 2024 | GRANT_AWARD | SAB Biotherapeutics, Inc. | 20,000 | 0.00 USD | deriv |
| 15 Jul 2024 | GRANT_AWARD | SAB Biotherapeutics, Inc. | 2,326 | 0.00 USD | deriv |
| 15 Jul 2024 | GRANT_AWARD | SAB Biotherapeutics, Inc. | 4,447 | 0.00 USD | deriv |
| 15 Jul 2024 | GRANT_AWARD | SAB Biotherapeutics, Inc. | 44,202 | 0.00 USD | deriv |
| 15 Jul 2024 | GRANT_AWARD | SAB Biotherapeutics, Inc. | 5,815 | 0.00 USD | deriv |
| 03 Jun 2024 | GRANT_AWARD | Titan Machinery Inc. | 4,396 | 0.00 USD | |
| 05 Jun 2023 | GRANT_AWARD | Titan Machinery Inc. | 2,989 | 0.00 USD | |
| 07 Jun 2022 | GIFT | SAB Biotherapeutics, Inc. | 2,000,000 | — | |
| 07 Dec 2022 | GRANT_AWARD | SAB Biotherapeutics, Inc. | 82,987 | 1.21 USD | |
| 07 Dec 2022 | GRANT_AWARD | SAB Biotherapeutics, Inc. | 82,987 | — | deriv |
| 13 Sept 2022 | PURCHASE | SAB Biotherapeutics, Inc. | 10,000 | 0.73 USD | first after silence |
| 06 Jun 2022 | GRANT_AWARD | Titan Machinery Inc. | 2,889 | 0.00 USD | |
| 12 Oct 2021 | GRANT_AWARD | SAB Biotherapeutics, Inc. | 25,000 | 10.08 USD | |
| 12 Oct 2021 | GRANT_AWARD | SAB Biotherapeutics, Inc. | 25,000 | 10.09 USD | |
| 22 Oct 2021 | GRANT_AWARD | SAB Biotherapeutics, Inc. | 5,049,351 | — | |
| 13 Oct 2021 | GRANT_AWARD | SAB Biotherapeutics, Inc. | 20,800 | 10.10 USD | |
| 01 Oct 2021 | GRANT_AWARD | SAB Biotherapeutics, Inc. | 2,695 | 10.10 USD | |
| 14 Oct 2021 | GRANT_AWARD | SAB Biotherapeutics, Inc. | 5,092 | 10.10 USD | |
| 22 Oct 2021 | GRANT_AWARD | SAB Biotherapeutics, Inc. | 4,974,497 | — | |
| 22 Oct 2021 | GRANT_AWARD | SAB Biotherapeutics, Inc. | 11,632 | — | deriv |
| 22 Oct 2021 | GRANT_AWARD | SAB Biotherapeutics, Inc. | 11,632 | — | deriv |
| 22 Oct 2021 | GRANT_AWARD | SAB Biotherapeutics, Inc. | 23,264 | — | deriv |
| 22 Oct 2021 | GRANT_AWARD | SAB Biotherapeutics, Inc. | 69,793 | — | deriv |
| 22 Oct 2021 | GRANT_AWARD | SAB Biotherapeutics, Inc. | 47,777 | — | deriv |
1 purchase reported after at least 12 months of silence — most recent on 13 Sept 2022.